ROCKLAND TRUST CO

Bank

Position in NVS — Novartis AG

CIK 84616 HANOVER, MA

Position in NVS

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$262,819

-$16,408 QoQ

Shares Held

1,677

-8.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,200

of 1,603 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROCKLAND TRUST CO holds $129,433,318 across 10 Drug Manufacturers - General names. NVS ranks #9 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	490,049	$62,971,296
2	JNJ	Johnson & Johnson	78,477	$19,930,803
3	LLY	ELI LILLY & Co	16,303	$19,554,308
4	PFE	Pfizer Inc	430,196	$10,359,119
5	BMY	Bristol Myers Squibb Co	146,933	$8,466,278
6	ABBV	AbbVie Inc.	25,770	$6,484,762
7	GSK	GSK plc	16,672	$873,946
8	AMGN	Amgen Inc	778	$281,729

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$262,819	1,677	-8.3%	Shares	Sole	2026-07-08
2026-03-31	$279,227	1,828	-5.2%	Shares	Sole	2026-04-16
2025-12-31	$265,951	1,929	+4.3%	Shares	Sole	2026-01-15
2025-09-30	$237,244	1,850	0.0%	Shares	Sole	2025-11-06
2025-06-30	$223,868	1,850	-7.5%	Shares	Sole	2025-07-10
2025-03-31	$222,848	1,999	-12.9%	Shares	Sole	2025-04-16
2024-12-31	$223,326	2,295	0.0%	Shares	Sole	2025-01-14
2024-09-30	$263,970	2,295	0.0%	Shares	Sole	2024-10-03
2024-06-30	$244,325	2,295	-8.2%	Shares	Sole	2024-07-23
2021-09-30	$204,531	2,501	-5.4%	Shares	Defined	2021-10-25
2021-06-30	$241,147	2,643	-4.6%	Shares	Defined	2021-07-21
2021-03-31	$236,865	2,771	+4.9%	Shares	Defined	2021-04-22
2020-12-31	$249,484	2,642	-2.7%	Shares	Other	2021-01-04
2020-09-30	$236,009	2,714	-6.2%	Shares	Other	2020-10-08
2020-06-30	$252,587	2,892	-2.7%	Shares	Other	2020-07-09
2020-03-31	$244,958	2,971	—	Shares	Other	2020-04-16
No filing history on record for this holder in this stock.